Screening for Symptoms of Depression and Anxiety in Adolescents and Young Adults With Cystic Fibrosis

Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, OH 45229, USA.
Pediatric Pulmonology (Impact Factor: 2.7). 02/2011; 46(2):153-9. DOI: 10.1002/ppul.21334
Source: PubMed


Although studies have assessed symptoms of depression and anxiety in individuals with cystic fibrosis (CF), few have been conducted since the advent of new medical treatments (e.g., nebulized antibiotics, ThAIRpy Vest). Study objectives were to: (1) document symptoms of depression and anxiety for adolescents and young adults with CF and compare with normative values, (2) examine the associations among depressive/anxiety symptoms and gender, age, lung function, and body mass index, and (3) determine the relations between adolescent and caregiver symptoms of depression and anxiety.
Patients and caregivers completed the Hospital Anxiety and Depression Scale (HADS) anytime (e.g., beginning or end) during routine CF clinic appointments.
Participants included 59 adolescents/young adults with CF (M(age)  = 15.8 years, 54% female, 98% Caucasian, M(FEV1% predicted)  = 84.6) and caregivers of 40 adolescents. Although symptom scores were in the normative range for patients with CF (M(Depression)  = 2.27 and M(Anxiety)  = 5.59), 3% and 32% exhibited clinically elevated symptoms of depression and anxiety, respectively. Symptoms of depression and anxiety were significantly associated with age (r = 0.28, 0.36). Symptoms of depression and anxiety were also positively correlated (r = 0.48). Females endorsed higher anxiety symptoms than males. While adolescent and caregiver anxiety scores were not related, higher caregiver depressive symptoms were associated with older patient age and worse lung function.
Data from the current study suggest low levels of depressive symptoms and substantial levels of anxiety symptoms in adolescents and young adults with CF. Consistent with prior literature, depressive symptoms appear higher in older patients and are significantly associated with anxiety symptoms. Caregiver symptomology appears to be more affected by an adolescent's health status, suggesting a need to screen caregivers when health begins to decline.

Download full-text


Available from: Kimberly A Driscoll, Jun 20, 2014
  • Source
    • "Not surprising, children and adolescents with CF often report higher rates of depression and anxiety than the general population [13] which is also associated with non-adherence to airway clearance and insecure attachment to parents [14]. One study reported 32% of adolescents and young adults with CF had clinical levels of anxiety and 3% had clinical levels of depression [15]. Another study showed anxiety and depression in adolescents and young adults with CF to be lower than in healthy controls [16]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Background: The impact of improved nutritional status on health-related quality of life (HRQOL) is unknown for children with cystic fibrosis (CF). Methods: Associations between nutritional status and HRQOL were examined over 2 years in 95 children, aged 9-19 years, who were followed in the Wisconsin Newborn Screening Project. HRQOL was assessed using the Cystic Fibrosis Questionnaire (CFQ). Associations between height z-score (HtZ), BMI z-score (BMIZ) and seven CFQ dimensions were evaluated. Results: Mean values of at least 80 were observed for all CFQ dimensions except respiratory symptoms and treatment burden. Treatment burden was significantly worse in patients with meconium ileus (57) compared to pancreatic insufficient (65) and sufficient (78) subjects, p<0.0001. HtZ and BMIZ were positively associated with physical functioning and body image (p<0.05). Conclusions: Better nutritional status was associated with increased HRQOL scores. Early diagnosis through newborn screening and improved nutrition provides an opportunity to enhance quality of life and body image perception.
    Journal of cystic fibrosis: official journal of the European Cystic Fibrosis Society 02/2013; 12(6). DOI:10.1016/j.jcf.2013.01.006 · 3.48 Impact Factor
  • Source
    • "One potential reason for the lower overall mean levels of quality of life compared to other studies may be due to the over-representation of females within the current sample population. Prior research has established that females with CF tend to fair worse medically than males (Nick et al., 2010), experience higher levels of anxiety (Goldbeck et al., 2010; Modi et al., 2011), lower self-esteem (Abbott et al., 2007) and lower HRQoL (Abbott, 2009). However, it is unlikely to be the full explanation as average scores for males alone in the HRQoL domains, with the exception of social functioning, are also lower than Sawicki et al.&apos;s (2011) sample. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Research from the general population indicates an important role for self-esteem in mental health, but limited research in this area exists in the cystic fibrosis (CF) literature. This study aimed to explore the predictive value of self-esteem and health-related quality of life (HRQoL) in mental health symptoms in adults with CF. Seventy-four participants, recruited online, completed the Clinical Outcomes in Routine Evaluation-Outcome Measure 34 (CORE-OM), Rosenberg Self-esteem Scale and Cystic Fibrosis Questionnaire-Revised (CFQ-R). Comparably high levels of self-esteem were found, but HRQoL was lower than previous research. Thirty percent of participants scored within the clinical range for mental health difficulty. Hierarchical regression, controlling for gender, explored the value of four CFQ-R subscales (physical, social, emotional and role functioning) and self-esteem in predicting CORE-OM total score. Gender accounted for 8.2 % of the variance in mental health scores while the five independent variables accounted for a further 73.0 % of variance. Of the five variables, CFQ-R emotional functioning and self-esteem were significant predictors of mental health symptoms. Results are discussed in relation to clinical implications and potential uses for internet technologies to promote socialisation.
    Journal of Clinical Psychology in Medical Settings 12/2012; 20(3). DOI:10.1007/s10880-012-9346-8 · 1.49 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Adult cystic fibrosis (CF) patients are an expanding cohort that is taken care of in a variety of hospital settings including adult centers located within pediatric institutions. This study compared costs and discharge rates among adult CF patient hospitalizations in terms of location of hospitalization. The 2007 Nationwide Inpatient Sample was utilized to identify adult CF patient admission data on patients aged 18-44. Data were separated into pediatric and adult facilities based on percentage discharge rate for patients >18. Primary outcomes measures were length of stay (LOS) and total hospital charges. Secondary predictors were geographic, primary payer, and co-morbidity effects on LOS and total hospital charges. LOS was higher for adult CF patient admissions in pediatric facilities compared to adult facilities by a mean of 2.5 days. Mean total hospital charges were not significantly different. Adult hospitals in the Western U.S. had a mean total charge more than $50,000 greater than any region in the U.S. Self-pay patients had significantly fewer hospital days and charges across all hospital types. Adult facilities had 7% more CF patients discharged home with home healthcare use. Depressed CF patients had longer LOS by 1.5 days regardless of facility type. LOS for adult CF inpatient admissions was significantly lower in adult facilities compared to pediatric facilities without a significant difference in hospital charges and is influenced by geographic hospital location. Depressed patients had longer lengths of stay regardless of facility type. Self-insured adult CF patients have a significant reduction in LOS and hospital charges when compared to all other payers regardless of hospital type.
    Pediatric Pulmonology 05/2011; 47(3):245-51. DOI:10.1002/ppul.21535 · 2.70 Impact Factor
Show more